[Federal Register Volume 67, Number 120 (Friday, June 21, 2002)]
[Notices]
[Page 42277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15771]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel, Phase 1 and 2 study of 
surveillance, safety, and immunogenicity of investigational Shigella 
vaccines in adults and children 5 to 7 years old and 1 to 4 years 
old in China.
    Date: July 12, 2002.
    Time: 12:00 pm to 1:30 pm.
    Agenda: To review and evaluate contract proposals.
    Place: 6100 Executive Blvd., DSR Conf. Rm., Rockville, MD 20852. 
(Telephone Conference Call).
    Contact Person: Hameed Khan, PHD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, National Institutes of Health, 
6100 Executive Blvd., Room 5E01, Bethesda, MD 20892. (301) 496-1485.

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, 
Contraception and Infertility Loan Repayment Program; 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research, National 
Institutes of Health, HHS)

    Dated: June 13, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-15771 Filed 6-20-02; 8:45 am]
BILLING CODE 4140-01-M